Pidilizumab

• Target :

  PD-1/PD-L1

• Related Pathways :

  Cell Cycle/Checkpoint|||Immunology/Inflammation|||Apoptosis

• Bioactivity :

  Pidilizumab (CT-011), a humanized IgG1? anti-PD-1 monoclonal antibody, serves as a DLL1 antagonist with potential applications in researching hematologic malignancies [1].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1036730-42-3